International Biotechnology Trust’s Agios Pharmaceuticals AGIO Stock Holding History

International Biotechnology Trust’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$594K	Hold	24,000	–	–	0.2%	57
2023 Q2	$680K	Buy	+24,000	New	+$597K	0.21%	54
2022 Q3	–	Sell	-476	Closed	-$21.5K	–	67
2022 Q2	$21.5K	Sell	476 -21,024	-98%	-$475K	0.22%	63
2022 Q1	$707K	Hold	21,500	–	–	0.16%	62
2021 Q4	$707K	Hold	21,500	–	–	0.16%	65
2021 Q3	$992K	Hold	21,500	–	–	0.24%	55
2021 Q2	$1.19M	Hold	21,500	–	–	0.31%	49
2021 Q1	$1.11M	Hold	21,500	–	–	0.29%	46
2020 Q4	$932K	Hold	21,500	–	–	0.25%	46
2020 Q3	$752K	Hold	21,500	–	–	0.24%	47
2020 Q2	$1.14M	Hold	21,500	–	–	0.38%	39
2020 Q1	$762K	Sell	21,500 -15,000	-41%	-$693K	0.35%	39
2019 Q4	$1.74M	Hold	36,500	–	–	0.63%	37
2019 Q3	$1.18M	Hold	36,500	–	–	0.55%	37
2019 Q2	$1.82M	Hold	36,500	–	–	0.68%	38
2019 Q1	$2.46M	Hold	36,500	–	–	0.91%	35
2018 Q4	$1.32M	Hold	36,500	–	–	0.82%	30
2018 Q3	$2.16M	Hold	36,500	–	–	1.03%	30
2018 Q2	$3.07M	Hold	36,500	–	–	1.18%	29
2018 Q1	$2.98M	Buy	36,500 +16,500	+83%	+$1.28M	1.16%	24
2017 Q4	$1.14M	Hold	20,000	–	–	0.4%	52
2017 Q3	$1.33M	Sell	20,000 -17,000	-46%	-$1.02M	0.52%	39
2017 Q2	$1.9M	Buy	37,000 +17,000	+85%	+$869K	0.72%	40
2017 Q1	$1.17M	Buy	+20,000	New	+$959K	0.45%	45

Other funds holding AGIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

International Biotechnology Trust's AGIO Position: Q3 2023 in Review

International Biotechnology Trust held its Agios Pharmaceuticals (AGIO) position steady in Q3 2023 at 24,000 shares worth $594K. The position accounts for 0.2% of the portfolio, ranked #57.

International Biotechnology Trust first reported a position in AGIO in Q1 2017 and has held it in 24 quarters since. The position peaked at $3.07M in Q2 2018. 145 funds tracked by Wall St. Rank hold AGIO as of Q3 2023.

International Biotechnology Trust held 24,000 shares of Agios Pharmaceuticals worth $594K as of Q3 2023.
International Biotechnology Trust left its Agios Pharmaceuticals share count unchanged in Q3 2023.
Agios Pharmaceuticals made up 0.2% of International Biotechnology Trust's portfolio in Q3 2023, its #57 holding.
International Biotechnology Trust first reported a position in Agios Pharmaceuticals in Q1 2017 and has held it in 24 quarters since.
International Biotechnology Trust's Agios Pharmaceuticals position peaked at $3.07M in Q2 2018.
145 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.